Sign in
4

Changes in Ownership

INOVIO PHARMACEUTICALS, INC. Filed Acc 0001055726-21-000007

Chief Operating Officer sold 28,336 shares at an average $15.05 ($426,383)

  • Chief Operating Officer acquired 22,376 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Shea Jacqueline Elizabeth · Chief Operating Officer

Table I: Non-derivative

3 lines
Date Transaction Shares Price Value Owned after D/I
2021-02-01 Exercise or conversion : show line 1 in the form +22,376 $3.62 $81,001 66,871 D
2021-02-01 Sale : show line 2 in the form −22,376 $15.06 $336,983 44,495 D
2021-02-01 Sale : show line 3 in the form −5,960 $15.00 $89,400 38,535 D
Open-market sales · 28,336 sh · avg $15.05 · $426,383

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2021-02-01 Exercise or conversion : show line 4 in the form Common Stock Option −22,376 100,000 D
Loading xslF345X03/wf-form4_161239754472771.xml…